PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

U.S. Optical Imaging Technologies to Benefit from Technical Advances and Rising Uptake in Certain Application Areas Says Frost & Sullivan - Growth in Clinical Diagnostics and Drug Discovery Markets
U.S. Optical Imaging Technologies to Benefit from Technical Advances and Rising Uptake in Certain Application Areas Says Frost & Sullivan

 

NewswireToday - /newswire/ - Mountain View, CA, United States, 2009/06/19 - Growth in Clinical Diagnostics and Drug Discovery Markets.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The use of optical technologies in clinics is currently limited due to restricted availability of validated data and low end-user awareness. However, technological advances, along with manufacturers' emphasis on promoting end-user education, are likely to result in some optical technologies, such as optical coherence tomography (OCT) and fluorescence spectroscopy, gaining market presence in certain applications such as ophthalmology, dentistry, and cancer screening over the next five to ten years.

New analysis from Frost & Sullivan (drugdiscovery.frost.com), Strategic Analysis of Optical Imaging Technologies in U.S. Clinical Diagnostics and Drug Discovery Markets, finds that the market earned revenues of over $75.60 million in 2007 and estimates this to reach $302.40 million in 2014.

If you are interested in further information about the study, please send an email to Johanna Haynes, at johanna.haynes[.]frost.com, with your full name, company name, title, telephone number, company email address, company website, city, state and country.

"Optics-based technologies have the potential to improve the accuracy of pathological diagnosis and expedite the process of drug discovery," says Frost & Sullivan Senior Research Analyst Madhu Sharma, Ph.D. "Additionally, exponential growth in biomarkers and reagent tools support the development of optical tools for drug discovery applications."

Optical technologies are likely to be an ideal method for the future, as they support breadth of applications, have low costs, and are non-invasive. Overall, this market is still in its infancy; however, it has seen notable improvements in the last decade. Certain segments have seen increased growth in recent years, such as OCT for ophthalmic and dental applications and fluorescence imaging.

Optical technologies in the clinical imaging market have considerable potential for growth in the next five to ten years, stemming from their vital role in the early diagnosis of diseases. Applications in the field of oncology and cardiovascular diseases are likely to be a part of the growing list of applications benefiting from non-invasive optical methods. Developing applications and ease-of-use are likely to drive the growth of optical technologies in drug discovery markets.

At the same time, the prevalence and wide acceptance of alternative technologies are deterring manufacturers from investing heavily in the development of innovative optical methods. Furthermore, availability of limited validated data is slowing adoption among physicians for diverse applications. The widespread use of confocal microscopy as a standard practice is limiting the growth of optical methods in in-vitro optical imaging for drug discovery applications.

"Many alternative technologies such as mechanical devices, digital radiography, and fluorescence-based devices have a strong presence in the dental OCT market, making manufacturers reluctant to invest heavily in the development of new optical methods for dental applications," continues Dr. Sharma. "Moreover, most physicians outside academia practice evidence-based medicine. Therefore, limited validated clinical data using optical methods is restricting adoption among tier II end users, including physicians in hospitals and clinics outside the academic arena."

An emphasis on educating physicians, publishing cost-benefit analysis about new technology, and collaborating with academic institutions to generate more validation data for diverse applications is likely to strengthen the presence of optical methods in clinical imaging markets.

Strategic Analysis of Optical Imaging Technologies in U.S. Clinical Diagnostics and Drug Discovery Markets is part of the Drug Discovery & Clinical Diagnostics Growth Partnership Service program, which also includes research in the following markets: U.S. Radiopharmaceutical Agents Markets, U.S Flow Cytometry Markets, U.S. Cell-Based Assays Markets, and U.S. Pre- Clinical Small Animal Imaging Markets. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 35 offices on six continents.

Strategic Analysis of Optical Imaging Technologies in U.S. Clinical Diagnostics and Drug Discovery Markets / N4DE

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


U.S. Optical Imaging Technologies to Benefit from Technical Advances and Rising Uptake in Certain Application Areas Says Frost & Sullivan

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Frost & Sullivan |
Publisher Contact: Johanna Haynes 
210.247.3870 johanna.haynes[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe
FDA Grants Priority Review to Genentech’s Lucentis® (Ranibizumab Injection) Supplemental Biologics License Application
Genentech’s TECENTRIQ® (Atezolizumab) Shows Significant Survival Advantage Compared to Chemotherapy

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  BizJobs.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)